coronary angiography Contrast-associated acute kidney injury occurred in 9.5% and 9.1% of patients receiving IV sodium bicarbonate and acetylcysteine, respectively, rates which did not differ ...

A rapid bolus injection of sodium bicarbonate immediately before contrast use drastically reduces the rate of contrast induced nephropathy (CIN) compared with sodium chloride in patients with mild ...

Hospira announced a voluntary recall of one lot of Sodium Bicarbonate Injection 8.4%, USP, due to particulate presence within a single-dose glass fliptop vial from a confirmed complaint. Hospira ...

Intravenous sodium bicarbonate and oral acetylcysteine are widely used to prevent acute kidney injury and associated adverse outcomes after angiography without definitive evidence of their efficacy.

According to the Company, intravenous administration of the affected product could lead to “site specific infections as well as serious systemic infections which may be life-threatening.” SterRx, LLC ...

Sodium bicarbonate is an antacid medication that can help treat people with kidney disease who develop metabolic acidosis. Kidney disease, also known as “chronic kidney disease” (CKD), is a condition ...

This leaflet answers some common questions about Sodium Bicarbonate Intravenous Infusion. It does not contain all the available information. It does not take the place of talking to your doctor or ...

A strategy of hydration with sodium chloride (saline) is more effective than bicarbonate for preventing contrast-induced nephropathy (CIN) in patients with renal dysfunction undergoing intravascular ...

Hospira recalls one lot of 8.4% Sodium Bicarbonate Injection, USP, due to particulate matter found within a single-dose glass fliptop vial. Hospira, a Pfizer company, announced on March 18, 2016 that ...

Trials that compared sodium bicarbonate and sodium chloride for the prevention of contrast-induced acute kidney injury have yielded highly conflicting results. The authors of a recent meta-analysis ...

Hospira, a unit of Pfizer, issued a voluntary recall of sodium bicarbonate and lidocaine HCI injectables due to the possible presence of glass particles in the vials. Monday, Hospira said it recalled ...